Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Clinical trial SYNERGY-AI is an AI-based precision oncology matching and registry study sponsored by Massive Bio, currently recruiting acros…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
The clinical trial update reports that the study on spontaneous regression in metastatic melanoma and renal cell carcinoma remains active bu…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy [Phase 1]
A Phase 1 trial evaluating NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy for patients with advanced cancers; the st…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 clinical trial evaluating molecular residual disease-guided adjuvant therapy in renal cell carcinoma; currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy [Phase 2]
A Phase 2 clinical trial update evaluating RP2 in combination with tivozanib for metastatic renal cell carcinoma after progression on immuno…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies [Phase 1]
A Phase 1 study of JANX008 in advanced or metastatic solid tumors is currently recruiting, evaluating multiple indications including Non-Sma…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 clinical trial is evaluating sequential cabozantinib therapy for advanced renal cell carcinoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma [Phase 4]
A Phase 4 clinical trial evaluating digital monitoring of self-reported symptoms in patients with advanced renal cell carcinoma treated with…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a CD70-targeted CAR-T therapy for CD70-positive advanced solid tumors is currently recruiting, enrolling patient…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer [Phase 2]
Phase 2 neoadjuvant immuno-oncology trial for primary clear cell renal cell carcinoma. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy [Phase 2]
Phase 2, prospective, single-arm multicenter study evaluating JS004 in combination with toripalimab for unresectable or advanced renal cell …
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors [Phase 2]
Phase 2 clinical trial update for BL-B01D1 in patients with multiple solid tumors, including locally advanced or metastatic urinary system t…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma [Phase 4]
Phase 4 clinical trial evaluating cabozantinib in combination with nivolumab for older patients with renal cell carcinoma is currently recru…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Comparison of Outcomes and Surgical Time Between Cortical and Medullary Suture vs. Medullary-Only Suture: Cortex Clinical Trial [NA]
This clinical trial update reports a study comparing cortical and medullary suturing techniques versus medullary-only suturing in renal cell…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC) [Phase 1]
Phase 1 clinical trial updating on the effects of belzutifan on PET tracer uptake (89Zr-DFO-girentuximab) in patients with renal cell carcin…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery [Phase 2]
Phase 2 trial exploring adding CBM588 to pembrolizumab for renal cell carcinoma after surgery; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Registry Platform Urologic Cancer
An ongoing clinical trial update from iOMEDICO AG describing a recruiting study for renal cell carcinoma and urothelial carcinoma.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
This multicenter retrospective study uses CT-based radiomics to predict MIT family translocation kidney cancer in renal cell carcinoma.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study
Multicenter clinical trial update evaluating serological autoantibodies as biomarkers for early diagnosis and prognosis of renal cell carcin…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer [Phase 1, Phase 2]
Scancell's Modi-1 Moditope is being studied in Phase 1/2 trials across several cancers, including triple-negative breast cancer, renal cell …
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
A clinical trial is evaluating the combination of PD-1/PD-L1 immune checkpoint inhibitors with radiotherapy across several cancers to assess…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC [Phase 2]
A Phase 2 clinical trial is evaluating preoperative therapy with super-selective tumor artery embolization combined with toripalimab and axi…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors [Phase 1, Phase 2]
An ongoing Phase 1/2 study investigates systemic VSV-IFNβ-NIS in combination with checkpoint inhibitors for select solid tumors. The trial i…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk [Phase 2]
A Phase 2 clinical trial is evaluating PET/CT-guided decisions to keep metastatic renal cell carcinoma patients free of systemic therapy. Th…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for GI-108, a bispecific anti-CD73-IL-2v fusion protein, being studied as monotherapy in advanced or metasta…